Image
|
Figure Caption
Figure 3
Light/Dark Test. (A) Average time spent in dark zone. No significant differences were observed. (B) Average velocity. Swimming velocity significantly decreased after treatment with 5 and 15 mg/L chlordiazepoxide. (C) Average immobility. No significant differences were observed. (D) Representation of time spent in the dark zone, velocity, and immobility on PC1 and PC2. (E) PC1 scores. No significant differences were observed. (F) PC2 scores. No significant differences were observed. Significant differences are indicated by *(P < 0.05) and **(P < 0.01). When applicable, all data is shown as mean ± S.E.M.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Sci. Rep.